ACLARION INC
ACONNASDAQTrading Snapshot
- Day Range
- $2.01 – $2.06
- 52-Week Range
- $1.85 – $9.36
- Volume (shares)
- 12,462
- Avg Volume (shares)
- —
- Shares Outstanding
- 2.9M
- Next Earnings
- 2026-11-11
Fundamentals Snapshot
- Annual Revenue
- $75,730
- Last Q Revenue
- $25,208
- P/E Ratio
- -0.3
- P/S Ratio
- 70.2x
- EPS (TTM)
- $-3.74
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +41400.5%
ACLARION INC
ACON
StockOtter · stockotter.spaceAbout ACLARION INC
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
ⓘLatest News & Updates
Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
BROOMFIELD, Colo., Oct. 22, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) –Aclarion, Inc.
Aclarion to Present at the 20th Annual LD Micro Main Event
BROOMFIELD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Aclarion (NASDAQ: ACON) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
PR Audio: BROOMFIELD, Colo., October 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc.
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
PR Audio: BROOMFIELD, Colo., September 29, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc.
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update
Aclarion, Inc. (NASDAQ: ACON - Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 76,007 shares, an increase
Reviewing OptimizeRx (NASDAQ:OPRX) & Aclarion (NASDAQ:ACON)
OptimizeRx (NASDAQ: OPRX - Get Free Report) and Aclarion (NASDAQ: ACON - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strengt